Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection

Fig. 2

EBV DNA changes in NPC patients infected with SARS-CoV-2. A Changes in EBV-DNA concentrations in patients who did not relapse with undetectable EBV DNA (no-relapse) and in patients who experienced relapse with consistently detectable EBV DNA (yes-relapse). B Typical case of EBV DNA changes in one yes-relapse patient and one no-relapse patient who underwent timely follow-up and examination

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us